We are very pleased to welcome CSL Behring, one of the largest biotech companies in the world, as a partner in BaseLaunch Phase II. Read the full press release to hear more on the partnership, and the three strategic platforms that CSL Behring is currently focusing...

Special Report: The latest addition to the partner portfolio all the way from Asia Pacific. A warm welcome to Bridge Biotherapeutics, for which CEO, James Lee, commented: “In joining BaseLaunch, centered in the Basel Area, a major hub for life sciences innovation in Europe, our team...

We welcome back Roivant Sciences with open arms for the continuation of their partnership with BaseLaunch Phase II. Sascha Bucher, Head of Global Transactions at Roivant Sciences, stated “We are proud to continue our partnership with BaseLaunch and support its mission of building companies that...

We are proud to announce that BB Pureos Bioventures has become a partner in BaseLaunch Phase II as the first venture capital fund. Anja Harmeier, Partner at BB Pureos Bioventures, stated: “We are delighted to join BaseLaunch as a partner in the next phase of...

We are proud to announce that Roche has become a founding partner in the next phase of BaseLaunch. With this commitment, Roche renews its partnership with us. “We are very pleased to continue our commitment to BaseLaunch. Basel has always been home to great ideas...

We are proud to announce that Roche has become a founding partner in the next phase of BaseLaunch. With this commitment, Roche renews its partnership with us. “We are very pleased to continue our commitment to BaseLaunch. Basel has always been home to great ideas...